Manipal Journal of Nursing and Health Sciences
Volume 3
Issue 1 MJNHS

Article 14

1-1-2017

Blinding in Randomized Controlled Trials: What researchers need
to know?
Vishnu Renjith Mr
Manipal College of Nursing, vishnurenjith@yahoo.co.in

Follow this and additional works at: https://impressions.manipal.edu/mjnhs
Part of the Public Health Commons

Recommended Citation
Renjith, Vishnu Mr (2017) "Blinding in Randomized Controlled Trials: What researchers need to know?,"
Manipal Journal of Nursing and Health Sciences: Vol. 3: Iss. 1, Article 14.
DOI: Available at: https://impressions.manipal.edu/mjnhs/vol3/iss1/14

This Review Article is brought to you for free and open access by the MAHE Journals at Impressions@MAHE. It has
been accepted for inclusion in Manipal Journal of Nursing and Health Sciences by an authorized editor of
Impressions@MAHE. For more information, please contact impressions@manipal.edu.

Review papers

Blinding in Randomized Controlled Trials: What researchers
need to know?
Vishnu Renjith
Email: vishnurenjith@yahoo.co.in

Abstract
Randomized Controlled Trial (RCT) is a classical research design, in which the participants are randomly allocated to
one or other treatment conditions under the study. Researchers widely use randomized trials to evaluate the effectiveness
of various pharmacological and non-pharmacological interventions. At the outset, randomization minimizes the bias
in allocating subjects to the intervention and control group. However, it does not exclude the chances of differential
treatment of groups or biased adjudication of outcome variables. Blinding helps in controlling various types of biases
that might inadvertently sweep into the study. The two major biases that can be controlled using blinding are the
performance bias and the ascertainment bias. The four groups of people blinded in the trial are the study subjects, the
research investigator/s, the outcome assessor/s, and the data analyst/s. Based on the number of people blinded, trials
are classified as open label trial, single blinded trial, double blinded trial, triple blinded trial, and quadruple blinded
trial. Sometimes, it may be difficult or nearly impossible to do blinding because of methodological, technical, or ethical
reasons. Researchers must ensure transparency in reporting the blinding. If, blinding was employed, mentioning the
study as ‘double blinded’ or ‘triple blinded’ may not be sufficient. The researchers must explicitly report, which all
individuals were blinded and how. Blinded RCTs can minimize bias to a greater extent. Blinding helps in prevention
of biased ascertainment of outcomes and reduce the chance of co-interventions. Researchers must strive to blind as
many individuals as practically feasible to limit the bias in RCTs.
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Introduction
Randomized Controlled Trial (RCT) is a classical
research design, in which the participants are randomly
allocated to one or other treatment conditions under the
study. RCTs help in authentic explanation of causality.
Randomization is the cardinal feature of an RCT and
it refers to the random allocation of subjects to the
study arms. RCTs provide the investigator the assurance
that the difference in the outcomes among subjects in
study arms was solely caused by the intervention, as
randomization equalizes the study group in all other
factors. Thus, RCTs set the standard of excellence in
undertaking health sciences research (Bench, Day, &
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Metcalfe, 2013; Polit & Beck 2012; Nelson, 2011 &
Kendal, 2003).
Researchers widely use randomized trials to evaluate
the effectiveness of various pharmacological and
non-pharmacological interventions. In health sciences
research, RCTs are usually done to evaluate, whether
a treatment or intervention is successful in-bringing
about desired changes in behavior, improving the
quality of life, or promoting symptom alleviation.
Because of its methodological rigor and its ability to
ascertain causality, RCTs are considered as the gold
standard for conducting medical research. At the outset,
randomization minimizes the bias in allocating subjects
to the intervention and control group; however, it does
not exclude the chances of differential treatment of
groups or biased adjudication of outcome variables
(Karanicolas, Farrokhyar & Bhandari, 2010). Blinding
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helps in controlling these types of biases that might
inadvertently sweep in the study.
The objectives of this article are to introduce the
concept of blinding, outline the importance of
blinding, discuss the classification of trials based on
blinding, and present the potential benefits of blinding.
Blinding
To reduce bias and to ensure the methodological
rigor, the investigators should plan the trial in such a
way that the study subjects, investigators encountering
the study subjects, individuals collecting the outcome
measures, and those who are analyzing the data,
have no knowledge regarding allocation status of the
study participants. Blinding is defined as “Keeping
trial participants, investigators (usually health-care
providers), or assessors (those collecting outcome data)
unaware of the assigned intervention, so that they will
not be influenced by that knowledge.” (Schulz and
Grimes, 2004)
Importance of blinding
Randomization eliminates the influence of
confounding factors or biases that are present at the
time of allocation. However, it does not eliminate the
confounders that may sweep-in after the allocation
has taken place. Blinding can play a major role in
controlling these post randomization confounders.
Hence, blinding is as important as randomization in
RCT (Hulley, Cummings, Browner, Grady & Newman,
2013). The absence of blinding can result in various
types of biases. The two major biases that can be
controlled using blinding are the performance bias and
the ascertainment bias.
Performance bias: The differences in care or attention
provided, to the subjects in different arms are referred
to as performance bias (Polit & Beck, 2012). The extra
attention given to the participants, in the intervention
arm is referred to as “co-intervention.” In an unblinded
study, the co-intervention might influence the difference
in outcome measures between the study groups. This
is also referred as co-intervention bias (Hulley et al.,
2013). For example, in an unblinded study to evaluate
the effect of counseling on smoking cessation, the
investigator’s keenness to find the benefit might lead
46

the investigator to ‘further motivate’ the client to stop
smoking. This ‘further motivation’, which is not part of
the intervention, is referred to as co-intervention. The
chances of co-intervention can be effectively limited
using blinding.
Ascertainment bias: Blinding can reduce the
ascertainment bias to a greater extend. If, the researcher
has foreknowledge about the treatment assignment
of a study participant, it may influence his or her
judgment in outcome assessment (Hulley et al., 2013).
This foreknowledge may unduly influence the way how
outcome variables are measured, verified, or recorded.
This kind of a bias is termed as ascertainment bias
(detection bias). For example, in an unblinded trial to
evaluate the effectiveness of ‘nurse-led interventions’
in improving the quality of life of patients diagnosed
with cancer, the investigator may get biased during the
adjudication of outcome variables. Subjective outcome
measures such as physical measurements, self-reported
scales, and disease diagnoses are all susceptible to
ascertainment bias. The ideal method to protect
the trial against an ascertainment bias is to keep the
individuals involved in the trial (more specifically the
outcome assessors) unaware of the allocation status.
Classification of trials based on blinding
The four groups of people blinded in the trial arethe study subject/s, the research investigator/s, the
outcome assessor/s, and the data analyst/s. Based on
the number of people blinded, trials are classified as
open label trial, single blinded trial, double blinded trial,
triple blinded trial, and quadruple blinded trial.
Open label trial: When blinding is not used in a
trial, the trial is referred to as an ‘open label trial.’ An
open label RCT is also referred to as an open RCT,
open trial, non-blinded trial, or unblinded trial. In
the case of unblinded trials, all the people involved
in the trial will be aware of the group assignment of
study participants. An open-label RCT evaluated the
effectiveness of music therapy in reducing the anxiety
of patients undergoing Micrographic Mohs Surgery
(MMS). Subjects were randomly assigned to- with
music and without music group. Due to the nature of
the intervention (music), it was impossible to blind the
subjects as well as the surgeon (Vachiramon, Sobanko,
Rattanaumpawan, & Miller, 2013).
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Single blinded trial: A single blinded trial involves
blinding of any one group of individuals. Usually, the
subjects receiving the intervention or the outcome
assessors are blinded to the intervention assignments.
Polkki and colleagues (2008) tested the effectiveness of
an imagery-induced relaxation intervention in reducing
post-operative pain among children aged eight to
12 years. In this single blinded study, the nurse who
collected the data did not know whether, children were
in the treatment group or in the usual care control
group.
Double blinded trial: In a double blinded trial, any two
groups of individuals are blinded. Double blinding is
recommended in drug trials. Usually, the investigators
as well as the study participants, are blinded to the
allocation status. Noehren et al. (2014) conducted a
placebo controlled trial to evaluate the effectiveness of
Transcutaneous Electrical Nerve Stimulation (TENS)
on outcomes of patients with fibromyalgia. In this
double blinded trial, the participants were blinded to the
active and placebo TENS treatments and the outcomes
assessor was blinded to the group assignments. Blinding
of the investigator was not feasible as he administered
the TENS intervention for the study subjects.
Triple blinded trial: Three groups of people are
blinded to the intervention assignments in a triple
blinded study. Usually, the subjects, the investigators,
and the outcome assessors are blinded. In RCT, on the
efficacy of doxycycline and rifampin for patients with
Alzheimer’s disease, the researchers utilized a triple
blinded design. Patients, investigators, and outcome
assessors were blinded to treatment allocation. The
three groups of individuals remained blinded during
the entire study period, including follow-up (Loeb et
al., 2004).
Quadruple blinded trial: If, all four groups of people
(study subjects, research investigators, outcome assessor,
and data analysts) are blinded to the allocation status
of the participants, the trial is referred as a quadruple
blinded study. Burns et al. (2005) conducted a study to
evaluate the effect of peri-operative n-acetylcysteine in
preventing renal dysfunction among high-risk patients
undergoing Coronary Artery Bypass Graft (CABG)
surgery. In these, placebo-controlled quadruple blinded

study patients, clinicians, data collectors, and the data
analysts were blinded to the group assignments of the
study subjects.
Potential benefits of blinding
The potential benefits of blinding are discussed based
on the type of individuals (study subjects, research
investigators, outcome assessors, and data analysts)
blinded.
Blinding subjects: The participants’ knowledge
of his or her assignment into the intervention arm
may operate a positive response, even if the therapy
had no positive clinical effect (Gordis, 2013). If,
the participants are not aware that they are getting
an experimental drug or placebo, then the clinical
outcomes are rarely influenced by their expectations of
its efficiency. Thus, blinding subjects helps in reduction
of expectation bias. Blinding of subjects is necessary,
when the outcomes are subjective in nature (like pain
and fatigue, etc.). Subjective outcomes are more prone
to expectation bias.
Blinding investigators;Blinding the investigators will
help to reduce the differential treatment provided
to the subjects in the intervention or control
groups. Investigators include doctors or nurses or
interventionists, who might interact with the subjects
during the trial. Schulz & Grimes (2004) reports that
the investigators ‘for or against attitude’ regarding an
intervention can directly be transferred to the study
subjects, if the investigators are not blinded. Blinding
the investigators thus help in preventing the delivery of
supplemental care or co-intervention to subjects in the
experimental arm.
Blinding outcome assessors:Blinding the outcome
assessor is crucial in ensuring the impartial assessment
of outcome variables. In studies involving subjective
outcomes, blinding the outcome assessors helps
in meticulous evaluation of outcomes. Unblinded
outcome assessors tend to register more generous
responses for the outcome variables of subjects in the
intervention arm (Schulz & Grimes, 2004).
Blinding the data analysts:The bias introduced at
the time of statistical analysis such as selective use of
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statistical tests as well as selective reporting of outcome
variables can be effectively controlled by blinding the
data analysts. The data analysts are blinded to the
study assignments till the completion of data analysis
(Karanicolas et al., 2010).

nursing journals, reported using blinding procedures
(Polit, Gillespie & Griffin, 2011).

Trials and blinding: Some practical considerations
Unlike randomization, blinding is always not possible.
The ability to blind a trial depends upon the nature of
trials and the nature of outcome variables. Sometimes
it may be difficult or nearly impossible to do blinding
because of methodological, technical, or ethical
reasons. In situations when, the subjects are assigned
to interventions like surgical, dietary, educational,
behavioral, psychological, exercise, or rehabilitation, it
is non-feasible to blind the participants.

Blinding or masking: Which terminology to use?
‘Blinding’ or ‘Masking’ are the two common
terminologies used to describe the same procedure.
Morris, Fraser, & Wormald (2007) recommends
the use of the term ‘masking’ in trials pertaining
to ophthalmology, as the term ‘blind’ refers to an
ophthalmologic condition and as an outcome variable.
The majority of health science researchers use the
term blinding rather than masking. Since, blinding
is predominantly used in medical literature, it is
recommended to use the terminology ‘blinding’ rather
than ‘masking’ (Schulz, Altman, & Moher, 2007; Schulz
& Grimes, 2004).

In a study to evaluate the effectiveness of gait training
program for patients with paraplegia, the participants
know what intervention they are receiving, and the
research interventionist know who received what
intervention. In these types of situations, it is nearly
impossible to blind the investigators and study subjects.
However, the researchers can explore the possibility
of blinding the outcome assessors. Blinding outcome
assessors are mostly feasible and considerably easy to
implement. Even though, blinding procedures help to
reduce bias and enhance validity, only 33% of the 199
published RCTs from 2007 to 2009 published in 16

Allocation concealment and blinding
There has been a considerable amount of confusion even
among researchers regarding allocation concealment
and blinding (Schulz & Grimes, 2004). Both the
techniques are used to control confounding variables.
Allocation concealment is a part of randomization.
Allocation concealment protects the randomization
sequence until the subjects are allocated to the study
arms, thus preventing selection bias, whereas blinding
helps in preventing the ascertainment bias (Figure 1).
It is always possible to achieve allocation concealment,
whereas the blinding is not.

Figure 1: Allocation concealment and blinding
48
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Reporting blinding in research reports
Despite its methodological importance, blinding is
often poorly reported in the trial reports (Hróbjartsson
et al., 2009). The updated Consolidated Standards of
Reporting Trials (CONSORT) guidelines demand
transparent reporting of blinding process (Moher
et al., 2010). Researchers must ensure transparency
in reporting blinding. If, blinding was employed,
mentioning the study as ‘double blinded’ or ‘triple
blinded’ may not be sufficient. The researchers must
explicitly report, which all individuals were blinded
and how. If, blinding was not possible, the researchers
must justify the reason regarding the same. If, blinding
was not employed, the researchers may consider it as a
limitation and acknowledge it in the report.
CONSORT statement recommends reporting on,
“How the success of blinding was evaluated?” Various
methods have been proposed to assess the success of
blinding in RCTs (Kolahi, Bang, & Park, 2009). The
researchers can check the successfulness of blinding
by asking the study subjects, research investigator,
outcome assessor, and data analysts, which intervention
(active intervention or placebo or do not know) they
think was administered to a particular group. If the
blinding was successful, the individuals will not be
able to successfully guess the treatment assignment. A
double blinded placebo controlled trial was conducted
to evaluate the effectiveness of chlorhexidine (CHX)
gluconate chewing gum on anti-plaque activity. In this
study, the researchers asked the participants to guess
the treatment they received (active or placebo or do
not know). The participants’ guess for the CHX gum
and placebo were not statistically significant, indicating
successful blinding (Kolahi, Soolari, Ghalayani,
Varshosaz, and Fazilaty, 2008).
Conclusion
Blinding is a significant methodological feature of
randomized trials. It involves concealing information
regarding group assignment from participants,
investigators, outcome assessors, and data analysts.
Blinded RCTs can minimize bias to a greater extent.
Blinding helps in prevention of biased ascertainment of
outcomes and reduce the chance of co-interventions.
Researchers must strive to blind as many individuals

as practically feasible to limit the bias in randomized
controlled trials.
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